A distinct subset of CD8+ T cells expressing intermediate levels of CD161, with characteristics of effector cytotoxic cells and capable of secreting IFNγ, GM-CSF, IL-17 and IL-22, were recently found to accumulate in the CSF and in brain lesions of MS patients (228). This evidence concerns the gene CD8A and myeloid sarcoma.